QUIDELORTHO
Quidel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of point-of-care (POC) diagnostic solutions for infectious diseases, and reproductive and women's health. It provides POC and other diagnostic tests under the QuickVue, QuickVue+, QuickVue Advance, Metra, Quidel, and MicroVue brand names. The company offers products for infectious diseases, such as Influenza, Group A Strep, and Respiratory Syncitial Virus; and for reproductive and women's h... ealth, including pregnancy, Chlamydia, Bacterial Vaginosis, and Bone Health. It also offers Immunoassay fecal occult blood test used to detect the presence of blood in stool specimens; and Helicobacter pylori test, a serological test to measure antibodies circulating in the blood caused by the immune response to the H. pylori bacterium. In addition, the company provides veterinary products; and clinical laboratory and research tests that are used in the measurement of circulating immune complexes, complement deficiencies, and complement activation. It sells its products to professionals for use in physician offices, hospitals, clinical laboratories, retail clinics, and wellness screening centers through a network of national and regional distributors, and a direct sales force in the United States, as well as through distributor arrangements primarily in Japan, Europe, and the Middle East. The company has an agreement with BioHelix Corporation for the development and commercialization of in vitro molecular diagnostic tests utilizing isothermal amplification technology. Quidel Corporation was founded in 1979 and is based in San Diego, California.
QUIDELORTHO
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Founded:
1979-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.quidel.com
Total Employee:
501+
Status:
Active
Contact:
8585526432
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Wordpress Plugins
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-23 | Ortho-Clinical Diagnostics | Ortho-Clinical Diagnostics acquired by QuidelOrtho | 6 B USD |
| 2017-07-17 | Alere - Triage Assets | Alere - Triage Assets acquired by QuidelOrtho | 400 M USD |
| 2017-05-16 | RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses | RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses acquired by QuidelOrtho | 14 M USD |
| 2016-03-18 | Immutopics | Immutopics acquired by QuidelOrtho | 5.5 M USD |
| 2013-10-24 | AnDiaTec | AnDiaTec acquired by QuidelOrtho | 7.3 M USD |
| 2013-05-07 | Biohelix | Biohelix acquired by QuidelOrtho | 10 M USD |
| 2010-01-12 | Diagnostic Hybrids | Diagnostic Hybrids acquired by QuidelOrtho | N/A |
| 2000-12-01 | Litmus Concepts | Litmus Concepts acquired by QuidelOrtho | 17.3 M USD |
| 1999-06-07 | Metra Biosystems | Metra Biosystems acquired by QuidelOrtho | 22.9 M USD |
| 1998-11-01 | Dade Behring - POC Urine Test Strip Business | Dade Behring - POC Urine Test Strip Business acquired by QuidelOrtho | N/A |
Investors List
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - QuidelOrtho
Official Site Inspections
http://www.quidel.com Semrush global rank: 310.12 K Semrush visits lastest month: 202.56 K
- Host name: 151.101.67.10
- IP address: 151.101.67.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
